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Abstract--- Ctenocephalides canis and Ctenocephalides felis 
felis are insects which are among the most common 
ectoparasites of common household dogs and cats. Flea killers 
have been developed for decades to counter this worldwide pest. 
It is a never-ending battle because of the continuous genetic 
resistance presented by the pest. In the present study, we 
applied a mixture of the pesticide Dinotefuran (26% w/v) and 
the synergist Piperonyl butoxide (6% w/v) to dogs (Solpreme 
Dog™ and cats (Solpreme Cat™) infested with the fleas via 
“Spot on” method. The treatment exterminated all of the fleas 
within 3 days (100%, p< 0.001). Re-infestation after 10 days 
caused an increase in the number of fleas, yet most of the effect 
lasted for at least 30 days. Further tests showed that the 
treatment is safe, water resistant, and has a long shelf life. The 
development of this novel mixture of substances provides an 
effective, safe means in the struggle with the continuous 
development of resistance to pesticides among major skin 
parasites. 
 
   Index Terms---cats, Ctenocephalides canis and felis, 
Dinotefuran, Dogs, Piperonyl butoxide. 
I. INTRODUCTION 
Ctenocephalides canis and Ctenocephalides felis felis are 
insects which are among the most common ectoparasites of 
dogs and cats [1].   Their distribution is global and is 
magnified by the fact that their hosts regularly live in close 
proximity with human. Fleas present serious medical issues 
to also human due to their ability to carry and transmit 
diseases through blood by biting their hosts. In addition to the 
direct action they possess as ectoparasites, they exert an 
indirect action as well by transferring numerous 
endosymbionts or pathogens including bacteria, protozoa and 
helminths that they carry, either directly or as intermediate 
hosts [2]. Another significant economic factor is that 
Ctenocephalides have an ability to develop resistance to 
pesticides, necessitating a constant effort to develop new 
products.  The present study was designed to test the efficacy 
of a mixture containing dinotefuran and piperonyl butoxide, 
in concentrations developed at the laboratories of Solano 
(Solpreme Dog™ and Solpreme Cat™), for the 
extermination of these skin parasites in dogs and cats. 
Dinotefuran is a neonicotinoid belonging to the newer 
generations of pesticides found effective to control a wide 
range of pests in agriculture [3]. Dinotefuran binds to a 
specific site on the insect cholinergic receptor, different than 
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the site where the neonicotinoids normally bind. The binding 
is very long lasting causing unceasing nerve stimulation 
making it a fast and effective insecticide [4].  
Piperonyl butoxide (PBO) is an insecticide synergist, a 
chemical that is used to enhance the potency of insecticides 
[5]. PBO acts as a synergist by inhibiting the P450 enzymes 
which break down the insecticides, prolonging their activity 
[6]. Today, dinotefuran and piperonyl butoxoide are being 
used on pets but have not been used together in the same 
product until now. We have hypothesized that because of 
their efficacy and their known safety of margin, they could act 
synergistically in the mixture developed in Solano 
laboratories to become effective and safe spot-on drops for 
the treatment against Ctenocephalides in dogs and cats. 
There is a constant need to develop new generations of 
pesticides because of the increase of both toxicity to the 
parasite and safety for the host, human, other organisms, and 
the environment, and also to overcome resistance if 
developed. The success of an adulticide is by nature time 
limited because mutations for resistance to the substance 
quickly proliferate in the pest population. This major issue [1] 
was brought to light as early as the forties in relation to the 
diminishing effectiveness of DDT in the extermination of 
Pulex irritans [7]. Since then, resistance of Ctenocephalides 
felis to various levels organophosphates, pyrethrins, 
pyrethroids, carbamates, and fipronil has been reported 
[8-10]. Similarily, the use of Sevin, with the major active 
ingredient carbaryl is limited today because of its diminishing 
efficacy. Thus, the issue of countering developing genetic 
resistance to pesticides is central to pesticide control [11], and 
to date the most effective mean to cope with this challenge is 
the continuous development of new products. In this light, it 
is significant that dinotefuran maintains its efficacy, and 
notably, no resistance to date has developed [12]. 
Consequently, in the present study dogs and cats were 
infested with adult Ctenocephalides canis and felis fleas and 
were then treated with Dinotefuran (26% w/v) and Piperonyl 
butoxide (6% w/v) mixture (Solpreme Dog™ and Solpreme 
Cat™) by “Spot on” application. The efficacy of the 
treatment was assessed by parasite counting. The practicality 
of the substance in daily situations was confirmed by studying 
its efficacy in dogs that were wetted and by confirming its 
shelf life over a reasonable period. 
II. METHODS 
Dog study  
Animals and maintenance: The experiment used 47 dogs 
8 weeks to 12 years old, weighing from about 1.5 kg to 50 kg. 
Animals were housed in groups of 4 in 20m2 pens. They were 
fed with standard commercial dry dogs’ diet; water was 
provided ad lib. The dogs were acclimated for 10 days prior to 
the initiation of the study. The candidate animals were 
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examined by a veterinarian and their suitability was 
ascertained prior to inclusion in the study. Animals were free 
of infectious diseases, which could complicate the 
interpretation of the study results. Only animals in good 
health conditions were enrolled for the study. The study 
lasted for 30 days. Flea infestation: A mix of adult 
Ctenocephalides canis and felis fleas originating from dogs 
were collected and kept at 5-8 °C. Fifty fleas were placed in 
the groin, back and behind the ears of the dogs. After the body 
temperature of the fleas rose to a normal level they began to 
actively bite their hosts. Monitoring infestation and clinical 
signs: The level of infestation was monitored during the 
entire period of the experiment. All dogs were observed daily 
for the physical condition of their hair and for tangles 
between their shoulders. Clinical observations of the dogs 
after infestation: I. Veterinary observation: Changes in skin 
and fur, eyes and mucous membranes, respiratory system, 
circulatory system, autonomic and central nervous system, 
somatomotor activity, as well as behavior pattern were 
monitored. Particular attention was directed to observations 
of central nervous system signs (seizures, tremors and 
salivation), vomiting and diarrhea. II. Changes in body 
weight: Dogs were weighed at the beginning and end of the 
study. III. Blood tests: Blood samples for clinical tests were 
collected from the v. cephalica antebrachii before the first 
treatment (Test 1) and on day 30 (last day) of the study (Test 
2). The parameters for the tests were urea, creatinine, 
bilirubin, alkaline phosphatase (ALP), alanine 
aminotransferase (ALT), and aspartate aminotransferase 
(AST).   
Treatment of the flea infestation: The dogs in all study 
groups were treated after infestation with Dinotefuran (26% 
w/v) and Piperonyl butoxide (6% w/v) mixture (Solpreme 
Dog™). Drops were applied on the back of the neck (“Spot 
on” application), in doses based on preliminary studies 
according to dog’s weight, and were as follows – 4.0 ml for 
25 – 50 kg body weight, 2.5 ml for 10 – 25 kg, 1.0 ml for 4 – 
10 kg, and 0.4 ml for dogs and puppies weighing 1.5 – 4 kg.  
Re-infestations with fleas: On the tenth day (D10) of the 
study re-infestations were performed to assess the duration of 
efficacy of the treatment.  
Additional studies were conducted to establish certain 
properties of the anti-fleas mixture drops.  
The shelf life of the drops: The efficacy of the drops was 
tested on three year old batches. 
Safety tests for the anti-fleas treatment mixture: a) A 
safety test of the anti-fleas mixture drops was conducted by 
treating a group of dogs and pups with 5 times higher and 
lower than the recommended dose. b) A safety test of the 
non-active ingredients was conducted with 5 times the 
recommended dose of control vehicle treatment that contains 
non-active, inert ingredients.  
Testing the water resistant properties of the substance: 
The efficacy of the drops was tested in treated dogs which 
were washed once daily throughout the study 
Evaluating the efficacy of the anti-fleas Solpreme 
treatment: Ectoparasite presence was monitored in animals 
in the efficacy test groups. Efficacy was monitored 
periodically throughout the entire test period. Efficacy was 
calculated as follows: 
 Cat study  
The procedure was similar to the dogs’ as described above. 
Changes specific to the cat study will be detailed. 
Animals and maintenance: The experiment used 47 cats 
and kittens 8 weeks to 12 years old, weighing from about 0.6 
to 8 kg. Eight weeks is the first age where the kittens are no 
longer sensitive to the toxic effect of the substance. Animals 
were housed in groups of 4 in 20m2 pens. They were fed with 
standard commercial dry cats’ diet; water was provided ad 
lib.  
Doses: Adult cats weighing more than 4 kg were treated 
with 0.8 ml, kittens and small cats between 0.6 – 4 kg with 0.4 
ml.  
All the rest of the procedures and tests were similar to 
those of the dogs’ (above), except that testing the water 
resistant properties of the substance and its shelf-life were 
not conducted.  
Ethical Standards 
 
Efficacy  = 
 
MFC  B  – MFC  A 
 
x 100% 
MFC  B  
 
B = before treatment,  A After treatment 
MFC = Mean Fleas Count 
 
 
 This study was based on EMEA/CVMP/EWP/005 
"Guideline for the Testing and Evaluation of the Efficacy of 
Antiparasitic Substances for the Treatment and Prevention of 
Tick and Flea Infestation in Dogs and Cats", OPPTS 
870.7200 “Companion Animal Safety”; and was performed 
with the approach to the OECD Principles of Good 
Laboratory Practice Directive 2004/10/EC and US FDA 
Good Laboratory Practice Regulations, 21 CFR Part 58. 
Ethical permit: License for Pharmaceutical Activities for 
Animal Studies No. 39-09-3-023, 08/06/2009 
III. RESULTS 
Global statistical analysis (ANOVA [13]) suggests that 
there are no statistical differences in dogs and cats regarding 
the level of infestation and the efficacy of eradication of the 
fleas across size, age and gender groups. Similarly, there were 
no statistical differences in the efficacy period between the 
different dog groups (no dog groups X efficacy interaction). 
Consequently, the results of the different sizes, ages and 
gender of the dogs and cats were pooled, and are presented 
and statistically analyzed accordingly. 
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As is shown in Table 1, no more than  24 hours are required 
for the anti-fleas treatment mixture drops to have a significant 
effect, eradicating 94% of the original flea population in dogs 
(P<0.001 for the difference between the first day of 
infestation where the treatment was applied and the second 
day). In the cat, the respective difference was 99% (P<0.001).  
After 3 and 10 days the eradication in both species was 
complete (100%) and there was a partial recovery of the flea 
populations on days 20 and 30. Still, the number of the fleas 
was significantly lower (P<0.001) than that of the original 
population. 
 
As is shown in Table 2. Long term storage for three years 
(shelf life) did not at all diminish the efficacy of Solpreme. 
Table 2. Additionally demonstrates the washing resistance of 
the of Solpreme anti-flea mixture. The dogs that were 
infested and treated with old Solpreme batch 
(Infested-Treated Old of Table 2) were also washed daily as 
described in Material and Methods. Washing the dogs (not 
done on the cats) had no effect on the efficacy of the anti-fleas 
mixture as their scores did not differ from those of the 
respective unwashed dogs. 
 All animals of all treatment groups showed normal health 
as monitored using the following criteria I. Body weight, II. 
Repeated veterinary examinations, III. Blood tests.  
I. Body weight: One indication of wellbeing and health 
after treatment is body weight which was not reduced, and in 
fact there was a small increase in body weight from the 
beginning to the end of testing in almost all groups (Table 3.) 
 II. Veterinary examinations: The results of the repeated 
veterinary examination were normal.  
Table 1:   I. The efficacy of Solpreme anti-flea mixture on 
eradicating the fleas in dogs and cats after infestation: percent 
eradication on different days after infestation (formula in 
Materials and methods), II.  Comparison between dogs and cats 
infested with fleas (infested) with their respective infested groups 
treated with Solpreme (Infested-Treated). Numbers are 
means±SEM of the percent eradication a day after infestation and 
in various intervals during the next 30 days. 
DOGS 
Day Infested 
(4) 
Infested-Treated 
(20) 
1 62±15 94±0.2 
*** 
3 77±14 100±0 
*** 
10
a 46±16 100±0 
*** †† 
20 31±13 99±1 
*** †† 
30 0±0 
 
87±4 
*** ††† 
CATS 
1 10±6 99±0.6 
*** ††† 
3 23±9 100±0 
*** ††† 
10
a 34±12 100±0 
*** ††† 
20 35±10 97±1 
*** ††† 
30 8±8 94±2 
*** ††† 
aThe animals were re-infested after counting on day 10. 
P<0.001 for the global treatment effect. 
*** P<0.001 for the statistical significance (multiple level 
ANOVA, match pairs) of the difference from day 0 (the day of 
infestation). 
†† P<0.01, ††† P<0.001, for the statistical significance of the 
difference between the Infested and the respected  
Infested-Treated  scores  
Table 2:    The effect of shelf life on the efficacy of Solpreme: 
Comparison between animal infested with fleas and treated with 
the new Solpreme mixture (Infested-Treated New) with their 
respective animals infested and treated Solpreme produced 
three years before (Infested-Treated Old). 
DOGS 
Day Infested-Treated 
Newb (20) 
Infested-Treated Old (4) 
1 62±15 90±5 
3 77±14 100±0 
10
a 46±16 100±0 
20 31±13 94±4 
30 0±0 68±9 
CATS 
1 10±6 99±1 
3 23±9 100±0 
10
a 34±12 100±0 
20 35±10 98±2 
30 8±8 94±4 
aThe animals were re-infested after counting on day 10. 
bSame group as treated dogs and cats as  
in Table 1. 
Numbers are means ±SEM of the percent eradication (efficacy) 
of Solpreme at various intervals during the 30 days after 
infestation and treatment.  
There were no statistical differences between groups 
(ANOVA). 
Table 3:   The effect of a 30-day treatment with Solpreme anti-flea 
mixture on the body weight of dogs and cats: comparison between 
dogs and cats infested with fleas (infested) with their respective 
infested groups treated with Solpreme (Infested-Treated). Numbers 
are the mean present body weight change/100 (±SEM) between the 
first and the last day of the experiment. 
Species 
Treatment 
(n)  
Body weight 
change 
Dogs Infested (4) 
0.63±0.19 
 
 
Infested-Treated 
(44) 
0.50±0.06 
Cats Infested (6) 
0.00±0.06 
 
 
Infested-Treated 
(41) 
0.11±0.03 
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III. Blood tests: Standard battery of veterinary blood tests 
was conducted. All parameters urea, creatinine, bilirubin, 
alkaline phosphatase (ALP), alanine aminotransferase 
(ALT), and aspartate aminotransferase (AST) were well 
within normal range. 
Safety tests for the anti-fleas treatment mixture: The 
safety test of the anti-fleas mixture included: treating a group 
of dogs and cats with 5 times higher and lower than the 
recommended dose. The safety test of the non-active 
ingredients included: 5 times the recommended dose of 
control vehicle treatment that contains non-active, inert 
ingredients. Both did not show any adverse effect on the 
tested dogs and cats.  
IV. DISCUSSION 
The present study confirms the efficacy and safety of the 
mixture Dinotefuran, a new generation pesticides and the 
synergist piperonyl butoxoide, in the concentration developed 
in Solano laboratories (Solpreme Dog™ and Solpreme 
Cat™) in exterminating the fleas Ctenocephalides canis and 
Ctenocephalides felis in dogs and cats, using the Spot On 
application method.  
While the combination of dinotefuran and piperonyl 
butoxide was tried for the control of other pests, for example 
as an enhancer of the efficacy of deltamethrin in mosquito 
control [14], the combination of the two pesticides in the 
concentration of dinotefuran 26% w/v and piperonyl butoxide 
6% w/v as is shown here is novel and has never been 
attempted commercially.  
Generally, toxicants were used in doses that appeared much 
less toxic to human and to the treated animals compared to 
the pests, without consideration of possible long-term effects. 
An archetypal example is the organophosphate family whose 
long-term effect on multiple systems was discovered only 
after many years of use. The central nervous system is a prime 
example where the Organophosphate Induced Delayed 
Neuropathy (OPIDN) was demonstrated [15]. It is significant 
therefore, that long-term toxicity of dinotefuran is long 
considered minor [16]. 
Piperonyl butoxide’s long-term neurotoxicity, especially in 
the low doses applied here, is slight and was considered as 
posing no neurological risk by the EPA [17]. 
Further consideration in using toxicants is their possible 
teratological effects [18], and in the present case of a nervous 
system toxicant, the neurobehavioral teratological effect [19, 
20]. The neurobehavioral teratogenicity of old generation 
pesticides such as the organophosphate, chlorpyrifos is well 
established [21, 22].  In addition to being less toxic to 
mammals than previous generation anti-fleas agents [23], 
both dinotefuran [24] and piperonyl butoxide [25, 26] appear 
to be non-teratogenic. However, there are indications that 
dinotefuran [24] and piperonyl butoxide [25] could be 
neurobehavioral teratogens and consequently we do not 
recommend their use during pregnancy. Still, further 
investigation is now required to confirm this notion.   
Pertaining to the issue of developmental toxicity is the 
mechanism by which piperonyl butoxide enhances the 
efficacy of various toxicants including dinotefuran, acting as 
a synergist by inhibiting the P450-microsomal oxidizing 
system, diminishing the pest’s ability to metabolize 
dinotefuran [5, 6]. The alterations in the oxidizing system are 
expected to be transient [27]. However, prenatal alteration of 
this system, for example induction of the microsomal 
oxidizing system by exposure to phenobarbital, uniquely lasts 
long into adulthood [28] adding to its potential 
developmental neurotoxicity and further supporting the 
recommendation for avoiding the use of Solpreme during 
pregnancy whenever possible.  
The distribution in the skin of pesticide administered 
topically to dogs was monitored in previous studies with 14C 
labelling. Radioactivity was detected inside the superficial 
epidermis, hair follicles and sebaceous glands which explains 
the water resistance of pesticide applied by the spot on 
procedure [29]. Indeed, in the present study the Solpreme 
efficacy was not diminished by repeated washing of the 
treated dogs.  
Criteria for shelf life of pesticides are clearly defined (J. 
Capizzi, OPEW (Vol. XI, No. 3). Data from several 
laboratories is available on the shelf life of dinotefuran [17] 
and piperonyl butoxide[30] and its adequacy is now 
recognized by the EPA. The present study demonstrates that 
the mixture of the two substances in the concentration 
presented here, containing the non-active, inert ingredients 
possess shelf life of at least three years making it practical for 
veterinary use. 
Solpreme was proven in the present study to be an effective 
treatment against Ctenocephalides canis and felis felis and 
still, safe for the dog and cat hosts. This was attested to by 
standard veterinary examinations, blood tests and monitoring 
body weight during the experimental period. Interestingly, 
body weight actually increased during the study, and this 
could be attributed to the continuous development of the 
young animals and to the weight increase with age in the adult 
animals. 
In summary, we used a combination of dinotefuran, a 
relatively safe and effective pesticide with proven efficacy in 
the extermination of Ctenocephalides canis and 
Ctenocephalides felis felis and piperonyl butoxide, a known 
pesticide synergist in our established concentrations for the 
extermination of the fleas in dogs and cats. The treatment is 
shown to be effective, safe, water (wash) resistant and to have 
a long shelf life. Currently, it appears as an effective mean in 
the struggle with the continuous development of resistance to 
pesticides among these skin parasites.  
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